Notice Number: NOT-HL-18-645
Key Dates
Release Date: August 21, 2018
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-16-021, "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)" will be extended by one council round (changes shown in bold italics below). This FOA has been modified to expire on January 19, 2019. NHLBI strongly encourage investigators focusing on sickle cell and other rare blood disorders such as bone marrow and hemophilia, to respond. Applicants are also encouraged to propose other omics including microbiome measurements to address a specific hypothesis.
Key Dates
The Key Dates table is updated accordingly:
Application Due Date(s) |
January 19, 2016, January 19, 2017, October 19, 2017, October 18, 2018, January 18, 2019 |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
June 2016, June 2017, March 2018, March 2019, June 2020 |
Advisory Council Review |
Not Applicable |
Earliest Start Date(s) |
September 2016, September 2017, July 2018, July 2019, September 2020 |
Expiration Date |
January 19, 2019 |
Due Dates for E.O. 12372 |
Not Applicable |
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Pankaj Qasba, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: qasbap@nhlbi.nih.gov
and Human Services (HHS)
